KOLs have traditionally exerted their influence through research and publication on drug safety and efficacy, but now share the stage with other important measures.
Paul Chew, MD
Advertisement
Articles by Paul Chew, MD
A discussion of the cost and time put into clinical trials.
Advertisement
Latest Updated Articles
Clinical Trials Don't Have to Cost Too Much or Take Too LongPublished: May 8th 2018 | Updated:
- KOLs: An Endangered Buzzword
Published: March 20th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
From Evidence to Access: How Real-World Data Delivers for Patients
2
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
3
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
4
WHO Finalizes United States’ Withdrawal from Organization: Report
5